ES2189357T3 - Compustos isocromano y procedimiento para su produccion. - Google Patents

Compustos isocromano y procedimiento para su produccion.

Info

Publication number
ES2189357T3
ES2189357T3 ES99310337T ES99310337T ES2189357T3 ES 2189357 T3 ES2189357 T3 ES 2189357T3 ES 99310337 T ES99310337 T ES 99310337T ES 99310337 T ES99310337 T ES 99310337T ES 2189357 T3 ES2189357 T3 ES 2189357T3
Authority
ES
Spain
Prior art keywords
production
compounds
isocromano
procedure
isochroman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99310337T
Other languages
English (en)
Inventor
Hideo Hirai
Hiroko Tonai
Toshio Ichiba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2189357T3 publication Critical patent/ES2189357T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)

Abstract

Compuestos isocromano y procedimiento para su producción. Esta invención se refiere a un nuevo compuesto isocromano o una sal farmacéuticamente aceptable del mismo, que es útil como inhibidor de la agregación de amiloide y en el tratamiento de la enfermedad de Alzheimer.
ES99310337T 1999-01-06 1999-12-21 Compustos isocromano y procedimiento para su produccion. Expired - Lifetime ES2189357T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IBPCT/IB99/00003 1999-01-06

Publications (1)

Publication Number Publication Date
ES2189357T3 true ES2189357T3 (es) 2003-07-01

Family

ID=11004809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99310337T Expired - Lifetime ES2189357T3 (es) 1999-01-06 1999-12-21 Compustos isocromano y procedimiento para su produccion.

Country Status (9)

Country Link
US (1) US6177458B1 (es)
EP (1) EP1018511B1 (es)
JP (1) JP3153212B2 (es)
AT (1) ATE231850T1 (es)
BR (1) BR9905981A (es)
CA (1) CA2291931C (es)
DE (1) DE69905131T2 (es)
DK (1) DK1018511T3 (es)
ES (1) ES2189357T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12185512B2 (en) 2007-11-16 2024-12-31 Manufacturing Resources International, Inc. Electronic display assembly with thermal management
US8654302B2 (en) 2008-03-03 2014-02-18 Manufacturing Resources International, Inc. Heat exchanger for an electronic display
US9573346B2 (en) 2008-05-21 2017-02-21 Manufacturing Resources International, Inc. Photoinitiated optical adhesive and method for using same
KR101868077B1 (ko) 2012-10-16 2018-06-18 매뉴팩처링 리소시스 인터내셔널 인코포레이티드 전자 디스플레이용 후방 팬 냉각 어셈블리
JP6971848B2 (ja) * 2015-09-29 2021-11-24 浜松ホトニクス株式会社 純粋なチオフラビンｔを精製する方法、純粋なチオフラビンｔの製造方法、チオフラビンｔを含有する組成物、及びアミロイドの検出方法
US10485113B2 (en) 2017-04-27 2019-11-19 Manufacturing Resources International, Inc. Field serviceable and replaceable display
WO2018200905A1 (en) 2017-04-27 2018-11-01 Manufacturing Resources International, Inc. System and method for preventing display bowing
US11096317B2 (en) 2019-02-26 2021-08-17 Manufacturing Resources International, Inc. Display assembly with loopback cooling
US10795413B1 (en) 2019-04-03 2020-10-06 Manufacturing Resources International, Inc. Electronic display assembly with a channel for ambient air in an access panel
US11477923B2 (en) 2020-10-02 2022-10-18 Manufacturing Resources International, Inc. Field customizable airflow system for a communications box
US11778757B2 (en) 2020-10-23 2023-10-03 Manufacturing Resources International, Inc. Display assemblies incorporating electric vehicle charging equipment
AU2022219982B2 (en) 2021-02-12 2024-10-17 Manufacturing Resources International, Inc. Display assembly using structural adhesive
CN113061631B (zh) * 2021-03-31 2022-09-16 华中科技大学 一种异色满类衍生物及其酶催化合成方法和应用
US11966263B2 (en) 2021-07-28 2024-04-23 Manufacturing Resources International, Inc. Display assemblies for providing compressive forces at electronic display layers
US12072561B2 (en) 2022-07-22 2024-08-27 Manufacturing Resources International, Inc. Self-contained electronic display assembly, mounting structure and methods for the same
US12010813B2 (en) 2022-07-22 2024-06-11 Manufacturing Resources International, Inc. Self-contained electronic display assembly, mounting structure and methods for the same
US12035486B1 (en) 2022-07-25 2024-07-09 Manufacturing Resources International, Inc. Electronic display assembly with fabric panel communications box
WO2025072596A1 (en) 2023-09-29 2025-04-03 Manufacturing Resources International, Inc. Extruded door frame subassembly, methods, and systems for producing the same
US12598727B2 (en) 2024-01-09 2026-04-07 Manufacturing Resources International, Inc. Double sided display assembly with bi-directional flow through a common, partitioned heat exchanger

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3145200B2 (ja) * 1992-09-02 2001-03-12 ファイザー製薬株式会社 新規イソクロマンカルボン酸誘導体

Also Published As

Publication number Publication date
CA2291931C (en) 2003-12-30
BR9905981A (pt) 2000-08-29
DE69905131T2 (de) 2003-06-05
EP1018511A1 (en) 2000-07-12
DK1018511T3 (da) 2003-06-23
EP1018511B1 (en) 2003-01-29
CA2291931A1 (en) 2000-07-06
JP2000198781A (ja) 2000-07-18
JP3153212B2 (ja) 2001-04-03
US6177458B1 (en) 2001-01-23
DE69905131D1 (de) 2003-03-06
ATE231850T1 (de) 2003-02-15

Similar Documents

Publication Publication Date Title
ES2189357T3 (es) Compustos isocromano y procedimiento para su produccion.
ECSP088499A (es) Nuevos compuestos de 2-amino-imidazol-4-ona y su uso en la fabricación de un medicamento para uso en el tratamiento de alteración cognitiva, enfermedad de alzheimer, neurodegeneración y demencia
PA8591701A1 (es) Derivados de pirrolopirimidina
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
BR0312729A (pt) Novos derivados de indol-3-enxofre
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
CR9721A (es) Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos
PE20020802A1 (es) COMPUESTO DE LACTAMA COMO INHIBIDOR DE LA LIBERACION DEL PEPTIDO ß-AMILOIDE
ECSP088969A (es) Amino-imidazolones y su uso como medicamento para tratar deficiencias cognitivas, enfermedad de alzheimer, neurodegeneración y demencia
ECSP055719A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
BR0111140A (pt) Forma polimórfica, composição farmacêutica, métodos para o tratamento de uma doença inflamatória, de uma doença mediada por ciclooxigenase, de dor, e, processo para fabricar um polimorfo de forma v
MXPA02006610A (es) Sustancias para uso al tratar psoriasis.
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
BR0208052A (pt) Composição que inibe matriz metaloproteinases para o tratamento de doenças neoplásicas
CO5190674A1 (es) Tratamiento de desordenes neuroticos desordenes neuroticos
ECSP034561A (es) Derivados puente de piperazina
ES2124983T3 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
SG151336A1 (en) 1,3,4-oxadiazol-2-ones as ppar delta
BR0315462A (pt) Composto, composição farmacêutica, uso de um composto, método para o tratamento de um sujeito que sofre de uma condição patológica ou de doença susceptìvel de alìvio por antagonismo de receptores de ltd4 e produto de combinação
NO20064982L (no) 1,3,4-oksadiazol-2-oner som PPAR delta modulatorer og anvendelse derav
ECSP014079A (es) Derivados de sulfonamida
EA200200948A1 (ru) Лечение псориаза